Extra shingles vaccine after organ transplant
Part of Infections clinical trials.
This study tests whether an extra dose of the Shingrix shingles vaccine can boost your protection against shingles after an organ transplant. It may help you stay healthier by strengthening your immune system's defenses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have received an organ transplant (like a kidney, liver, heart, or lung).
- You have already completed the two-dose Shingrix shingles vaccine series.
- It has been at least 6 months since your transplant and at least 6 months since your last Shingrix dose.
- You have not been treated for organ rejection recently (within the past 8 weeks, or 6 months if you received certain strong immune-suppressing drugs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether an additional Shingrix (RZV) vaccine dose helps prevent shingles in people who previously had an allogeneic bone marrow or stem cell transplant. It focuses on people who are at least a year out from their first two Shingrix doses.
This trial tests whether the shingles vaccine (RZV) is safe and works well for organ transplant recipients and their household members. It also includes people on dialysis or certain immunosuppressants.
This study tests the shingles vaccine in young adults who have had a solid organ transplant (like a kidney or liver) more than a year ago. The goal is to see if the vaccine works well and is safe for people on stable anti-rejection medicines.
This Phase 2 study looks at how well the shingles vaccine works in people who had an allogeneic (donor) stem cell transplant. It aims to measure the body’s immune response to the vaccine and check that it’s safe in this recovery period.
This Phase 3 study tests whether the shingles vaccine Shingrix is safe and effective for adults with chronic kidney failure who are on the transplant waiting list. It aims to protect you from shingles while you may be dealing with transplant-related immune changes.
This study tests a live, weakened shingles vaccine given as a booster after a different type of shingles vaccine. It may help strengthen your protection against shingles.
Hear when a new Zoster; Herpes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.